Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haplo-identical SCT with Post-Transplant Cyclophosphamide
NCT02053545Phase 2Withdrawn
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Dec 2013
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in leukemia, lymphoma, myelodysplastic syndrome (MDS), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Planned start Dec 2013; status: withdrawn.
02
Drugs
cyclophosphamide
03
Conditions
leukemialymphomamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02053545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053545.